TY - JOUR
T1 - Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus
AU - Garcia-Gonzalez, Araceli
AU - Richardson, Marsha
AU - Garcia Popa-Lisseanu, Maria
AU - Cox, Vanessa
AU - Kallen, Michael A.
AU - Janssen, Namieta
AU - Ng, Bernard
AU - Marcus, Donald M.
AU - Reveille, John D.
AU - Suarez-Almazor, Maria E.
N1 - Funding Information:
Acknowledgment This study is supported by a grant from the National Institute for Arthritis, Musculoskeletal and Skin Disorders (NIAMS; R01 AR47858) and, in part, by the Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. Dr. Suarez-Almazor has a K24 career award from NIAMS and is the Director of the Houston Center for Education and Research on Therapeutics funded by the Agency for Health Quality and Research (U18 HS016093).
PY - 2008/7
Y1 - 2008/7
N2 - This study assessed self-reported adherence in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) from underserved healthcare settings. We conducted a cross-sectional survey of 102 ethnically diverse patients - 70 with RA and 32 with SLE - attending rheumatology clinics at publicly funded hospitals in Houston, Texas; 43% were Hispanic, 32% African-American, and 25% White. Treatment adherence was evaluated using the compliance questionnaire rheumatology (CQR; 0, low adherence and 100, high adherence) and the questionnaire of the Adult AIDS Clinical Trials Group (AACTG). The patients were also asked how often they forgot to take their prescribed medications or discontinued them on their own. Mean patient age was 48.5 years; 75% were female, 32% were African-American, 43% Hispanic, and 25% White. Only one third reported never forgetting to take their medications; 40% reported having stopped their medications on their own because of side effects, and 20% because of lack of efficacy. Mean CQR score was 69.1 ± 10.5, suggesting moderate adherence overall. Differences were also observed across ethnic groups: 23% of ethnic minority patients had problems taking their medications at specified times compared to 11% of Whites (p = 0.03). Lower education and side effects were associated with lower adherence. No differences were observed between RA and SLE patients. Many patients with RA and SLE report problems with treatment adherence. These appear to be more prevalent in African Americans and Hispanics than Whites; the impact of decreased adherence on outcomes could be significant and should be considered when treating patients with RA and SLE.
AB - This study assessed self-reported adherence in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) from underserved healthcare settings. We conducted a cross-sectional survey of 102 ethnically diverse patients - 70 with RA and 32 with SLE - attending rheumatology clinics at publicly funded hospitals in Houston, Texas; 43% were Hispanic, 32% African-American, and 25% White. Treatment adherence was evaluated using the compliance questionnaire rheumatology (CQR; 0, low adherence and 100, high adherence) and the questionnaire of the Adult AIDS Clinical Trials Group (AACTG). The patients were also asked how often they forgot to take their prescribed medications or discontinued them on their own. Mean patient age was 48.5 years; 75% were female, 32% were African-American, 43% Hispanic, and 25% White. Only one third reported never forgetting to take their medications; 40% reported having stopped their medications on their own because of side effects, and 20% because of lack of efficacy. Mean CQR score was 69.1 ± 10.5, suggesting moderate adherence overall. Differences were also observed across ethnic groups: 23% of ethnic minority patients had problems taking their medications at specified times compared to 11% of Whites (p = 0.03). Lower education and side effects were associated with lower adherence. No differences were observed between RA and SLE patients. Many patients with RA and SLE report problems with treatment adherence. These appear to be more prevalent in African Americans and Hispanics than Whites; the impact of decreased adherence on outcomes could be significant and should be considered when treating patients with RA and SLE.
KW - Adherence
KW - Rheumatoid arthritis
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=45049088569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=45049088569&partnerID=8YFLogxK
U2 - 10.1007/s10067-007-0816-6
DO - 10.1007/s10067-007-0816-6
M3 - Article
C2 - 18185905
AN - SCOPUS:45049088569
SN - 0770-3198
VL - 27
SP - 883
EP - 889
JO - Clinical Rheumatology
JF - Clinical Rheumatology
IS - 7
ER -